StemInov
Pre-clinicalStemInov is developing a stem cell therapy for inflammatory diseases with a first focus on critical care: septic shock and ARDS
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $2.5M
About
StemInov is developing a stem cell therapy for inflammatory diseases with a first focus on critical care: septic shock and ARDS
Cell & Gene Therapy
Funding History
1Total raised:$2.5M
Seed$2.5MJun 15, 2021